ytterbium has been researched along with Ependymoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gilday, DL; Hosain, F; Longo, R; Reba, RC; Wagner, HN | 1 |
| Hosain, F; Reba, RC; Wagner, HN | 1 |
2 other study(ies) available for ytterbium and Ependymoma
| Article | Year |
|---|---|
Evaluation of ytterbium-169 diethylenetriaminepentaacetic acid as a brain-scanning agent.
Topics: Animals; Brain Neoplasms; Ependymoma; Humans; Neoplasm Transplantation; Neoplasms, Experimental; Pentetic Acid; Radionuclide Imaging; Technetium; Ytterbium | 1969 |
Ytterbium-169 diethylenetriaminepentaacetic acid complex. A new radiopharmaceutical for brain scanning.
Topics: Animals; Astrocytoma; Brain Diseases; Brain Neoplasms; Dogs; Ependymoma; Humans; Injections, Intravenous; Mice; Neoplasms, Experimental; Pentetic Acid; Radioisotopes; Radionuclide Imaging; Ytterbium | 1968 |